Esophageal Adenocarcinoma: New Treatments & Hope in Oncology Gastrointestinal 10 Mins Read4 Esophageal adenocarcinoma is a subtype of cancer that arises from the glandular cells in the esophagus, the muscular tube responsible…
Induction Chemotherapy with FTD/TPI and Oxaliplatin in Resectable EGAC: Preliminary Phase II Study Results Gastrointestinal 3 Mins Read19 Sarbajit Mukherjee, MD, MS, Assistant Professor, Roswell Park Comprehensive Cancer Center conducted a study to investigate the efficacy of a…
Trimodality: In addition to Trastuzumab for HER2+ Esophageal Adenocarcinoma: NRG Oncology RTOG 1010 Phase III Trial Lisa Kachnic MD Gastrointestinal 13 Mins Read1 Trimodality: In addition to Trastuzumab for HER2+ Esophageal Adenocarcinoma: NRG Oncology RTOG 1010 Phase III Trial Lisa Kachnic MD By…
